Navigation Links
HeartWare International Reports $54.8 Million In Third Quarter 2013 Revenue; 140% Increase From Third Quarter Of 2012
Date:11/7/2013

FRAMINGHAM, Mass., Nov. 7, 2013 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced revenue of $54.8 million for the third quarter ended September 30, 2013, a 140% increase compared to $22.9 million in revenue for the same period of 2012.

"During the third quarter, 549 HeartWare® Ventricular Assist Systems were sold globally, an increase from 256 units in the third quarter of 2012 and more than our previous high quarterly total of 523 units in the second quarter of 2013," said Doug Godshall, President and Chief Executive Officer.  "Our results for the third quarter reflect continued positive trends in the commercial launch of the HeartWare® System in the U.S., following approval from Food and Drug Administration (FDA) late last year, as well as continued strong support from our international customers."

During the third quarter of 2013, U.S. revenue, which reflects the company's third full quarter of U.S. commercialization, was $28.2 million, a significant increase from $3.6 million in the third quarter of 2012.  Revenue from international markets, generated through the sale of 287 units, was $26.6 million, an increase of approximately 38% from $19.3 million in the third quarter of 2012.

"Our strong commercial growth was complemented by advances made in clinical development, as we received full protocol approval from FDA for a supplemental patient cohort to our destination therapy trial and commenced enrollment last month," added Mr. Godshall.  "We also remain on track for initiation of first-in-human testing of our next generation MVAD® pump, with Pal co
'/>"/>

SOURCE HeartWare International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. HeartWare Receives FDA Approval To Enroll Supplemental Patient Cohort In Destination Therapy Trial
2. HeartWare Presentation At The Canaccord Genuity 2013 Annual Growth Conference To Be Webcast
3. HeartWare Receives Conditional Approval From FDA to Enroll Supplemental Patient Cohort in Destination Therapy Trial
4. HeartWare Presentation at the Wells Fargo Securities 2013 Healthcare Conference to be Webcast
5. HeartWare International Announces Intention To Delist From Australian Securities Exchange (ASX)
6. HeartWare Presentation At The Goldman Sachs 34th Annual Global Healthcare Conference To Be Webcast
7. HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast
8. HeartWare Presentation at the Bank of America Merrill Lynch 2013 Health Care Conference to be Webcast
9. HeartWare International Reports $49.2 Million In First Quarter 2013 Revenue; 87% Increase From First Quarter Of 2012
10. HeartWare Schedules First Quarter Conference Call And Webcast
11. HeartWare International, Inc. Announces Pricing of Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2014)... DUBLIN , Oct. 17, 2014 ... of the "Research and Development Prospect of ... offering. Based on the 2013 ... Chinese government policies about dialysis industry and the ... in-depth research about dialysis industry segmentations. Moreover, it ...
(Date:10/17/2014)... Oct. 17, 2014 A victim of medical negligence ... doctor with a history of alcohol abuse, a physician ... on Prop 46 today, highlighting how Prop 46 will identify ... testing. The ad pictures a doctor drinking ... To ER."  Proposition 46 will enact the first law in ...
(Date:10/17/2014)...  Talyst, a market leader in pharmacy automation will ... Nashville, TN. The company will ... for onsite, remote medication dispensing. Talyst,s ... and securely dispense medication onsite, on demand. Remote dispensing ... that the correct medication gets to the correct patient ...
Breaking Medicine Technology:Research and Development Prospect of China Dialysis Market, 2014-2018 2Research and Development Prospect of China Dialysis Market, 2014-2018 3Victim Of Negligence At Hands Of A Drunk Doctor, A Physician and Consumer Advocates Release New Yes on 46 TV Ad, "On Call" 2Victim Of Negligence At Hands Of A Drunk Doctor, A Physician and Consumer Advocates Release New Yes on 46 TV Ad, "On Call" 3Victim Of Negligence At Hands Of A Drunk Doctor, A Physician and Consumer Advocates Release New Yes on 46 TV Ad, "On Call" 4Talyst Exhibits at LeadingAge Annual Meeting 2
... 13, 2010 Amylin Pharmaceuticals, Inc. (Nasdaq: AMLN ... third quarter of 2010 on Wednesday, October 20, 2010 at ... and chief executive officer, will lead the call. On the ... third quarter of 2010.   The call will ...
... Following recent FDA approvals for prostate cancer treatment ... the lives of men with advanced prostate cancer ... from Johnson & Johnson. The drug, which could reach the ... with the potential to change clinical practice by providing ...
Cached Medicine Technology:Amylin Pharmaceuticals to Webcast Third Quarter Results 2Robotic Prostatectomy Expert Dr. David Samadi, MD Discusses Prostate Cancer Treatment Drug Abiraterone 2
(Date:10/20/2014)... MA (PRWEB) October 20, 2014 ... sponsoring a booth at the American Foundation for Suicide ... 25th. The AFSP is a not-for-profit organization that hosts ... Net proceeds from these events are used to help ... but education and personal relationships as well. , ...
(Date:10/20/2014)... October 20, 2014 hc1.com today ... secure cloud solution that enables healthcare organizations of ... ultimate healthcare-specific customer relationship management (“CRM”) solution. , ... unique needs of the healthcare industry, the hc1 ... providers and patients by combining healthcare CRM, HIPAA-compliant ...
(Date:10/20/2014)... (PRWEB) October 20, 2014 Principle Business ... takes pride in manufacturing top-of-the-line absorbent products. The ... of its most popular brand, Tranquility® Premium Protection absorbent ... a new website, gave its packaging a new look, ... the brand message to the public. , The new ...
(Date:10/20/2014)... 2014 Succeed is proud to announce that ... participated in the Every Body Walk! campaign by ... project that encourages workers to be more active outside of ... which concluded at the end of September, was a friendly ... metro areas. Participating companies gave their staff pedometers and ...
(Date:10/20/2014)... Ohio (PRWEB) October 20, 2014 Unveiled at ... new Strategic Direction Scorecard conservatively estimates member hospital ROI on ... spent on dues, The Center provides $12.50 in value to ... is (Member Value – Member Dues)/Member Dues. , “This ... at this number and we think the methodology is really ...
Breaking Medicine News(10 mins):Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 2Health News:The Advocator Group, LLC is Proud to Participate in an Out of the Darkness Community Walk, October 25th, to Increase Suicide Awareness 3Health News:Healthcare Relationship Management (HRM) Leader hc1.com® Launches hc1® Quick Start™ 2Health News:Tranquility® Premium Protection Incontinence Products Releases New Logo and Website 2Health News:Succeed Management Solutions, LLC Competes in Walking Challenge and Achieves 12th Place in Portland 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 2Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 3Health News:Scorecard Estimates Hospital ROI at $12.50 for every $1 Spent on Dues 4
... FORT LAUDERDALE, Fla., Dec. 10 Synovics,Pharmaceuticals, Inc. (OTC ... further reduction of its debt by paying off the,last ... the sale of,additional Series C Convertible Redeemable Preferred Stock ... As previously reported in the ...
... MIAMI, Dec. 10 Todobebe, Inc., a leading ... today the roll out,of its website property "embarazo.com", ... URL in 1999, and the new site reinforces ... trusted,content for Spanish speaking families globally. , ...
... LLC (Prime),announces that it has been chosen by Blue ... pharmacy benefit management services, beginning,January 1, 2009. , ... benefit services to more than 175,000 BCBSMT,members enrolled in ... covers a range of pharmacy benefit services including:,claims processing, ...
... to drive again , , WEDNESDAY, Dec. 10 (HealthDay News) -- ... after orthopedic surgery or injury, but knowing when it,s safe to ... surgeons weigh in on the issue in the December issue of ... "Deciding when a patient can return to driving is a difficult ...
... density, new analysis shows , , WEDNESDAY, Dec. 10 (HealthDay ... Actos, double the risk of fractures in women but ... Avandia (rosiglitazone) and Actos (pioglitazone) are used to lower ... studies have suggested that the risk for heart failure, ...
... Artist Toni Braxton and Her Son Featured in TV and ... YORK, Dec. 10 The Advertising Council, in partnership with ... of public service advertisements (PSAs) featuring Grammy award-winning recording artist ... about autism and to urge parents to learn the early ...
Cached Medicine News:Health News:Synovics Pharmaceuticals Announces Additional Investment by Svizera and Reduction of Debt 2Health News:Synovics Pharmaceuticals Announces Additional Investment by Svizera and Reduction of Debt 3Health News:Synovics Pharmaceuticals Announces Additional Investment by Svizera and Reduction of Debt 4Health News:Synovics Pharmaceuticals Announces Additional Investment by Svizera and Reduction of Debt 5Health News:Todobebe Rolls Out Embarazo.com for Pregnant Moms 2Health News:Prime Therapeutics Announces Blue Cross and Blue Shield of Montana as a Pharmacy Benefit Services Client 2Health News:Returning to the Road Tricky After Injury 2Health News:2 Diabetes Drugs Double Fracture Risk in Women 2Health News:2 Diabetes Drugs Double Fracture Risk in Women 3Health News:Video: The Advertising Council and Autism Speaks Launch New PSAs to Raise Awareness of Autism 2Health News:Video: The Advertising Council and Autism Speaks Launch New PSAs to Raise Awareness of Autism 3Health News:Video: The Advertising Council and Autism Speaks Launch New PSAs to Raise Awareness of Autism 4
Used to introduce balloon, closed and non-tapered end catheters or other devices for intervention....
Used to introduce balloon, diagnostic and guiding catheters, or other devices for intervention....
Used to introduce large devices for vascular intervention....
Used to introduce balloon, closed and non-tapered end catheters and other devices for intervention....
Medicine Products: